Skip to main content
. Author manuscript; available in PMC: 2013 Dec 11.
Published in final edited form as: J Neurovirol. 2012 Mar 13;18(2):10.1007/s13365-012-0089-y. doi: 10.1007/s13365-012-0089-y

Fig. 1.

Fig. 1

The symptomatic feature of HIV-associated neurocognitive disorders in these patients. a The total symptom score of HAND group was higher than that of non- HAND group (6.04 vs. 2.52). b The symptom score of cognitive impairment was very higher in HAND group (3.19 vs. 0.65), followed by that of behavior disorder (1.60 vs. 0.39). But the symptom score of motor impairment was not different between two groups (1.50 vs. 1.06). c The total symptom scores were different among ANI and MND and HAD (2.58 vs. 6.40 vs. 11.82). d Cognitive impairment scores increased as the disease development (0.83 vs. 3.70 vs. 6.27). Similarly, behavior disorder scores also increased as the disease development (0.65 vs. 1.65 vs. 2.55). Although the symptom score of motor impairment was higher in HAD compared with that in ANI and MND (3.0 vs. 1.09 and 1.05), no difference of that was found between ANI and MND. *Statistically significant at p< 0.05; **statistically significant at p<0.01